• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation.

作者信息

Lemaitre Florian, Luyt Charles-Edouard, Roullet-Renoleau François, Nieszkowska Ania, Zahr Noël, Fernandez Christine, Farinotti Robert, Combes Alain

出版信息

Intensive Care Med. 2010 Jul;36(7):1273-4. doi: 10.1007/s00134-010-1882-9. Epub 2010 Apr 8.

DOI:10.1007/s00134-010-1882-9
PMID:20376428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7095260/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/017d/7095260/12f3be90b046/134_2010_1882_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/017d/7095260/12f3be90b046/134_2010_1882_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/017d/7095260/12f3be90b046/134_2010_1882_Fig1_HTML.jpg

相似文献

1
Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation.一名接受血液透析滤过和体外膜肺氧合治疗的患者体内羧基奥司他韦的蓄积情况。
Intensive Care Med. 2010 Jul;36(7):1273-4. doi: 10.1007/s00134-010-1882-9. Epub 2010 Apr 8.
2
Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza.体外膜肺氧合和连续静脉-静脉血液透析滤过对重症甲型 H1N1 流感患者奥司他韦羧酸药代动力学的影响。
Ther Drug Monit. 2012 Apr;34(2):171-5. doi: 10.1097/FTD.0b013e318248672c.
3
Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique.羧基奥司他韦在重症患者中的药代动力学：每个患者都是独特的。
Intensive Care Med. 2013 May;39(5):977-8. doi: 10.1007/s00134-013-2851-x. Epub 2013 Feb 27.
4
Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.重症患者接受连续静脉-静脉血液透析和/或体外膜氧合时奥司他韦和奥司他韦羧酸的药代动力学。
Pharmacotherapy. 2012 Dec;32(12):1061-9. doi: 10.1002/phar.1151.
5
Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support.接受体外膜肺氧合支持的危重症成年患者中奥司他韦的药代动力学
Anaesth Intensive Care. 2013 Jan;41(1):66-73. doi: 10.1177/0310057X1304100112.
6
H1N1 influenza in pregnancy: cause for concern.妊娠期甲型H1N1流感：令人担忧的问题。
Obstet Gynecol. 2010 Jan;115(1):185. doi: 10.1097/AOG.0b013e3181c8ad6b.
7
Oseltamivir dosing for influenza infection in premature neonates.奥司他韦治疗早产儿流感感染的剂量。
J Infect Dis. 2010 Aug 15;202(4):563-6. doi: 10.1086/654930.
8
Adult respiratory distress syndrome caused by 2009 H1N1 influenza during pregnancy: success of ECMO for both the mother and the child.2009年甲型H1N1流感所致成人呼吸窘迫综合征合并妊娠：体外膜肺氧合支持下母婴均获成功救治
J Extra Corpor Technol. 2011 Jun;43(2):75-8.
9
Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.奥司他韦预防暴露于甲型 H1N1 流感病毒的新生儿的安全性和药代动力学。
Pediatr Infect Dis J. 2012 May;31(5):527-9. doi: 10.1097/INF.0b013e3182472f28.
10
Oseltamivir dosing in children undergoing hemodialysis.
Clin Infect Dis. 2010 May 15;50(10):1427-8. doi: 10.1086/652287.

引用本文的文献

1
Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.持续肾脏替代治疗期间抗菌药物剂量优化的建议。
Front Pharmacol. 2020 May 29;11:786. doi: 10.3389/fphar.2020.00786. eCollection 2020.
2
Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.体外膜肺氧合患者中氨基糖苷类药物峰浓度不足的预测因素。
Crit Care. 2018 Aug 19;22(1):199. doi: 10.1186/s13054-018-2122-x.
3
Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.

本文引用的文献

1
Safety and pharmacokinetics of oseltamivir at standard and high dosages.奥司他韦标准剂量和高剂量的安全性和药代动力学。
Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1.
2
Extracorporeal membrane oxygenation for pandemic (H1N1) 2009.2009年甲型H1N1流感大流行的体外膜肺氧合治疗
Emerg Infect Dis. 2009 Dec;15(12):2059-60. doi: 10.3201/eid1512.091434.
3
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.体外膜肺氧合期间伏立康唑和卡泊芬净的潜在螯合作用。
口服和静脉注射奥司他韦治疗需器官替代治疗的重症乙型流感病毒感染的药代动力学
Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):155-164. doi: 10.1007/s13318-016-0330-9.
4
Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.在用人全血预充的体外膜肺氧合回路中进行丙泊酚、咪达唑仑、万古霉素和环孢素的治疗药物监测。
Crit Care. 2015 Feb 12;19(1):40. doi: 10.1186/s13054-015-0772-5.
5
Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk.
Intensive Care Med. 2011 Feb;37(2):371. doi: 10.1007/s00134-010-2080-5. Epub 2010 Nov 20.
Intensive Care Med. 2009 Jan;35(1):183-4. doi: 10.1007/s00134-008-1269-3. Epub 2008 Sep 16.
4
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.奥司他韦混悬液在血液透析和持续性非卧床腹膜透析患者中的药代动力学及耐受性
Nephrol Dial Transplant. 2006 Sep;21(9):2556-62. doi: 10.1093/ndt/gfl267. Epub 2006 Jun 24.